Monarch Capital Management Inc. continued to hold its position in shares of Colgate-Palmolive Co. (NYSE:CL) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,349 shares of the company’s stock at the end of the second quarter. Monarch Capital Management Inc.’s holdings in Colgate-Palmolive were worth $538,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also modified their holdings of the company. National Pension Service raised its position in Colgate-Palmolive by 4.2% in the first quarter. National Pension Service now owns 448,007 shares of the company’s stock valued at $31,652,000 after buying an additional 17,928 shares during the last quarter. Legal & General Group Plc raised its position in Colgate-Palmolive by 1.3% in the first quarter. Legal & General Group Plc now owns 3,953,265 shares of the company’s stock valued at $279,300,000 after buying an additional 50,393 shares during the last quarter. Nisa Investment Advisors LLC raised its position in Colgate-Palmolive by 5.0% in the second quarter. Nisa Investment Advisors LLC now owns 288,977 shares of the company’s stock valued at $21,153,000 after buying an additional 13,835 shares during the last quarter. Artemis Investment Management LLP raised its position in Colgate-Palmolive by 30.3% in the second quarter. Artemis Investment Management LLP now owns 275,846 shares of the company’s stock valued at $20,188,000 after buying an additional 64,100 shares during the last quarter. Finally, Bank of Montreal Can purchased a new position in Colgate-Palmolive during the second quarter valued at about $64,888,000. Institutional investors and hedge funds own 72.97% of the company’s stock.
Colgate-Palmolive Co. (NYSE:CL) traded up 0.21% during trading on Friday, reaching $72.31. 2,874,972 shares of the company’s stock were exchanged. Colgate-Palmolive Co. has a 12 month low of $61.40 and a 12 month high of $75.38. The stock has a market cap of $64.46 billion, a PE ratio of 46.56 and a beta of 0.63. The firm has a 50 day moving average of $73.15 and a 200-day moving average of $72.54.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Thursday, July 28th. The company reported $0.70 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.01. The firm earned $3.85 billion during the quarter, compared to analyst estimates of $3.86 billion. Colgate-Palmolive had a return on equity of 1,980.28% and a net margin of 9.04%. The business’s quarterly revenue was down 5.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.70 earnings per share. On average, equities research analysts anticipate that Colgate-Palmolive Co. will post $2.79 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 15th. Stockholders of record on Monday, October 24th will be paid a dividend of $0.39 per share. This represents a $1.56 dividend on an annualized basis and a dividend yield of 2.16%. The ex-dividend date of this dividend is Thursday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 100.65%.
Several research analysts have issued reports on CL shares. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price target for the company in a report on Monday, October 3rd. Citigroup Inc. lifted their price objective on shares of Colgate-Palmolive from $82.00 to $88.00 and gave the company a “buy” rating in a research note on Friday, July 29th. Bank of America Corp. upgraded shares of Colgate-Palmolive from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $70.86 to $80.00 in a research note on Monday, September 12th. JPMorgan Chase & Co. reiterated a “hold” rating and issued a $75.00 price objective on shares of Colgate-Palmolive in a research note on Friday, July 29th. Finally, Deutsche Bank AG reiterated a “hold” rating and issued a $75.00 price objective (up previously from $73.00) on shares of Colgate-Palmolive in a research note on Sunday, July 24th. Fourteen research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $74.68.
In related news, COO Noel R. Wallace sold 78,849 shares of the company’s stock in a transaction that occurred on Tuesday, August 2nd. The stock was sold at an average price of $74.69, for a total transaction of $5,889,231.81. Following the completion of the transaction, the chief operating officer now owns 236,295 shares in the company, valued at $17,648,873.55. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, COO Franck J. Moison sold 15,000 shares of the company’s stock in a transaction that occurred on Thursday, August 11th. The shares were sold at an average price of $75.16, for a total value of $1,127,400.00. Following the transaction, the chief operating officer now owns 188,029 shares of the company’s stock, valued at approximately $14,132,259.64. The disclosure for this sale can be found here. Insiders own 1.05% of the company’s stock.
Colgate-Palmolive Company (Colgate) is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Company’s segments include Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic segments, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Co. (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Co. and related companies with MarketBeat.com's FREE daily email newsletter.